Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma
Clinical trial NCT00959686 · COMPLETED
Trial details
- NCT number
- NCT00959686
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.